NPLEx; require manufacturers of certain pseudoephedrine or ephedrine products to pay fees to support the administration of.

SB 2733 requires manufacturers of pseudoephedrine or ephedrine products sold in Mississippi to pay monthly fees to the National Association of Drug Diversion Investigators (NADI) starting October 1, 2025. These fees fund the administration of the National Precursor Log Exchange (NPLEx) system, which tracks over-the-counter sales of these products. Manufacturers must provide written proof of payment to the Mississippi State Board of Pharmacy upon request. The bill does not change existing sales limits (3.6g daily/7.2g monthly) or pharmacy requirements for using NPLEx.